Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S.
Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15.
TRENDS AND ALTERNATIVES IN TREATMENT OF MALIGNANT TUMORS OF EXTRAHEPATIC BILE DUCTS.
Stoyanov V, Dimitrova V.
Khirurgiia (Sofiia). 2015;81(3):149-60.
[Cholangiocarcinomas].
Schöning W, Haber PK, Pratschke J.
Chirurgie (Heidelb). 2025 Jan;96(1):77-86. doi: 10.1007/s00104-024-02200-z. Epub 2024 Dec 10.
Contrast-enhanced ultrasound examination of the gallbladder and bile ducts: A pictorial essay.
Cokkinos DD, Antypa EG, Tsolaki S, Skylakaki M, Skoura A, Mellou V, Kalogeropoulos I.
J Clin Ultrasound. 2018 Jan;46(1):48-61. doi: 10.1002/jcu.22537. Epub 2017 Oct 6.
Ultrasound of the bile ducts.
Mittelstaedt CA.
Semin Roentgenol. 1997 Jul;32(3):161-71. doi: 10.1016/s0037-198x(97)80004-1.
[Cholangiocarcinoma].
Burgos San Juan L.
Rev Med Chil. 2008 Feb;136(2):240-8. Epub 2008 May 7.
Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology.
Mocchegiani F, Vincenzi P, Conte G, Nicolini D, Rossi R, Cacciaguerra AB, Vivarelli M.
World J Gastroenterol. 2023 Oct 14;29(38):5361-5373. doi: 10.3748/wjg.v29.i38.5361.
Current controversies in cholangiocarcinoma.
Hoyos S, Navas MC, Restrepo JC, Botero RC.
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1461-1467. doi: 10.1016/j.bbadis.2017.07.027. Epub 2017 Jul 26.
Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors.
Liu Q, Zhang P, Li Q.
Discov Med. 2024 Jan;36(180):48-60. doi: 10.24976/Discov.Med.202436180.4.
Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
Lin MX, Ye JY, Tian WS, Xu M, Zhuang BW, Lu MD, Xie XY, Kuang M.
Dig Dis Sci. 2017 Apr;62(4):1086-1094. doi: 10.1007/s10620-016-4312-1. Epub 2017 Feb 15.
